Norrsken VC joins Tandem Health’s $100 million Series B financing

• Norrsken VC invested in Tandem Health, joining its investor group following the healthcare AI company's previously announced $100 million Series B.
• The Series B was led by the Scaleup Europe Fund, managed by EQT; LG Technology Ventures and T.Capital also joined the investor group.
• Funding will accelerate European adoption and development of Tandem's AI-native Clinic Operating System.
• Tandem's AI Medical Assistant supports clinical decisions and administrative tasks, serving more than 10,000 care organizations across 14 European markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stockholmsnorrskenet Management AB published the original content used to generate this news brief on October 27, 2026, and is solely responsible for the information contained therein.